These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29896102)

  • 1. Biomaterials for the Delivery of Growth Factors and Other Therapeutic Agents in Tissue Engineering Approaches to Bone Regeneration.
    Kowalczewski CJ; Saul JM
    Front Pharmacol; 2018; 9():513. PubMed ID: 29896102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Regeneration by Controlled Release of Bone Morphogenetic Protein-2: A Rabbit Spinal Fusion Chamber Molecular Study.
    Hu T; Naidu M; Yang Z; Lam WM; Kumarsing RA; Ren X; Ng F; Wang M; Liu L; Tan KC; Kwok KT; Goodman SB; Goh JC; Wong HK
    Tissue Eng Part A; 2019 Oct; 25(19-20):1356-1368. PubMed ID: 30727849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term controlled delivery of rhBMP-2 from collagen-hydroxyapatite scaffolds for superior bone tissue regeneration.
    Quinlan E; Thompson EM; Matsiko A; O'Brien FJ; López-Noriega A
    J Control Release; 2015 Jun; 207():112-9. PubMed ID: 25817394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteogenic potential of recombinant human bone morphogenetic protein-9/absorbable collagen sponge (rhBMP-9/ACS) in rat critical size calvarial defects.
    Nakamura T; Shirakata Y; Shinohara Y; Miron RJ; Furue K; Noguchi K
    Clin Oral Investig; 2017 Jun; 21(5):1659-1665. PubMed ID: 27726024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
    Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
    Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2.
    Krishnan L; Priddy LB; Esancy C; Klosterhoff BS; Stevens HY; Tran L; Guldberg RE
    Acta Biomater; 2017 Feb; 49():101-112. PubMed ID: 27940197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
    Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
    Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
    Boyne PJ
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
    Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
    J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects.
    Barboza EP; Caúla AL; Caúla Fde O; de Souza RO; Geolás Neto L; Sorensen RG; Li XJ; Wikesjö UM
    J Periodontol; 2004 May; 75(5):702-8. PubMed ID: 15212353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated osseous regeneration: the early events in the healing response.
    Freire MO; Kim HK; Kook JK; Nguyen A; Zadeh HH
    Tissue Eng Part A; 2013 May; 19(9-10):1165-74. PubMed ID: 23190409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.
    Blumenthal NM; Koh-Kunst G; Alves ME; Miranda D; Sorensen RG; Wozney JM; Wikesjö UM
    J Periodontol; 2002 Dec; 73(12):1494-506. PubMed ID: 12546100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs.
    Choi SH; Kim CK; Cho KS; Huh JS; Sorensen RG; Wozney JM; Wikesjö UM
    J Periodontol; 2002 Jan; 73(1):63-72. PubMed ID: 11852905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2--Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2--Genetics Institute/Medtronic-Sofamor Danek/Integra.
    BioDrugs; 2002; 16(5):376-7. PubMed ID: 12408742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated osseous regeneration: a novel strategy for bioengineering bone by immobilized anti-bone morphogenetic protein-2 antibodies.
    Freire MO; You HK; Kook JK; Choi JH; Zadeh HH
    Tissue Eng Part A; 2011 Dec; 17(23-24):2911-8. PubMed ID: 21870943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2.
    Kim IS; Lee EN; Cho TH; Song YM; Hwang SJ; Oh JH; Park EK; Koo TY; Seo YK
    Tissue Eng Part A; 2011 Feb; 17(3-4):337-48. PubMed ID: 20868206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chondroitin Sulfate Glycosaminoglycan Scaffolds for Cell and Recombinant Protein-Based Bone Regeneration.
    Andrews S; Cheng A; Stevens H; Logun MT; Webb R; Jordan E; Xia B; Karumbaiah L; Guldberg RE; Stice S
    Stem Cells Transl Med; 2019 Jun; 8(6):575-585. PubMed ID: 30666821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model.
    Liu Y; Lu Y; Tian X; Cui G; Zhao Y; Yang Q; Yu S; Xing G; Zhang B
    Biomaterials; 2009 Oct; 30(31):6276-85. PubMed ID: 19683811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering.
    Ji Y; Xu GP; Zhang ZP; Xia JJ; Yan JL; Pan SH
    Ann Biomed Eng; 2010 Mar; 38(3):632-9. PubMed ID: 20049636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.